Reformulated islatravir implant should provide PrEP for over a year
Large numbers now on Descovy PrEP in the United States
By 2030, a quarter of people taking HIV treatment in the US will be over 65 and most will have multiple health concerns
Ten-year Italian study shows that people with HIV remain undetectable for 97% of the time
Near point-of-care viral load tests slash waiting times in seven African countries
Binge drinking more likely to cause death or liver problems in people with HIV
US study suggests women living with HIV should be screened earlier for non-AIDS co-morbidities
Better access to PrEP in the UK, especially through NHS services
Younger age, problems obtaining PrEP, and worries about side effects among the factors associated with PrEP discontinuation in Germany
